These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 30074406)
1. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A. Yuan J; Zhang N; Zheng Y; Chen YD; Liu J; Yang M DNA Cell Biol; 2018 Sep; 37(9):750-757. PubMed ID: 30074406 [TBL] [Abstract][Full Text] [Related]
2. A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke. Zheng Z; Liu S; Wang C; Han X J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3535-3541. PubMed ID: 30197169 [TBL] [Abstract][Full Text] [Related]
3. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer. Tang Y; Wang Y; Wang X; Liu Y; Zheng K Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409 [TBL] [Abstract][Full Text] [Related]
4. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer. Sharifi R; Shahangian SS; Salehi Z; Mashayekhi F; Talesh Sasani S; Mirzanezhad L Asian Pac J Cancer Prev; 2020 Dec; 21(12):3705-3710. PubMed ID: 33369471 [TBL] [Abstract][Full Text] [Related]
5. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. Tao R; Hu S; Wang S; Zhou X; Zhang Q; Wang C; Zhao X; Zhou W; Zhang S; Li C; Zhao H; He Y; Zhu S; Xu J; Jiang Y; Li L; Gao Y Carcinogenesis; 2015 Oct; 36(10):1136-43. PubMed ID: 26163879 [TBL] [Abstract][Full Text] [Related]
6. Association Between the Deletion Allele of Ins/Del Polymorphism (Rs145204276) in the Promoter Region of GAS5 with the Risk of Atherosclerosis. Shen Z; She Q Cell Physiol Biochem; 2018; 49(4):1431-1443. PubMed ID: 30205366 [TBL] [Abstract][Full Text] [Related]
7. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer. Li Q; Ma G; Sun S; Xu Y; Wang B Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):478-482. PubMed ID: 29602737 [TBL] [Abstract][Full Text] [Related]
8. Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics. Lin CY; Wang SS; Yang CK; Li JR; Chen CS; Hung SC; Chiu KY; Cheng CL; Ou YC; Yang SF Int J Med Sci; 2019; 16(11):1424-1429. PubMed ID: 31673232 [TBL] [Abstract][Full Text] [Related]
9. Growth arrest-specific 5 (GAS5) insertion/deletion polymorphism and cancer susceptibility in Asian populations: A meta-analysis. Gao G; Liu C; Li X; Guan X; Yang X; Qin P Medicine (Baltimore); 2021 Oct; 100(41):e27415. PubMed ID: 34731115 [TBL] [Abstract][Full Text] [Related]
10. LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer. Zheng Y; Song D; Xiao K; Yang C; Ding Y; Deng W; Tong S Oncotarget; 2016 Dec; 7(50):83727-83734. PubMed ID: 27863421 [TBL] [Abstract][Full Text] [Related]
11. Association of LncRNA-GAS5 gene polymorphisms and PBMC LncRNA-GAS5 level with risk of systemic lupus erythematosus in Chinese population. Liu CH; Lu YL; Huang HT; Wang CF; Luo HC; Wei GJ; Lei M; Tan T; Wang Y; Huang YY; Wei YS; Lan Y J Cell Mol Med; 2021 Apr; 25(7):3548-3559. PubMed ID: 33728802 [TBL] [Abstract][Full Text] [Related]
12. LncRNA-GAS5 and its Promoter Region Polymorphism Associate with Helper Th17 Polarization and Predict Postoperative Pain and the Prognosis of the Patients with Hepatocellular Carcinoma Undergoing Hepatectomy. Sha Z; Zhang P Iran J Immunol; 2022 Dec; 19(4):349-357. PubMed ID: 36585876 [TBL] [Abstract][Full Text] [Related]
13. Association between long non-coding RNA (lncRNA) GAS5 polymorphism rs145204276 and cancer risk. Zhao S; Liu P; Ruan Z; Li J; Zeng S; Zhong M; Tang L J Int Med Res; 2021 Sep; 49(9):3000605211039798. PubMed ID: 34521242 [TBL] [Abstract][Full Text] [Related]
14. Genetic Variants of Deng F; Zhu P; Liao C; Li S; Hu X; Wang Y; Wu Z; Huang S; Zhong W; Zhao B; Ma G; Li Y Biomed Res Int; 2021; 2021():6634253. PubMed ID: 33937403 [TBL] [Abstract][Full Text] [Related]
15. Correlations of an Insertion/Deletion Polymorphism (rs10680577) in the RERT-lncRNA with the Susceptibility, Clinicopathological Features, and Prognosis of Lung Cancer. Zhu J; Luo JZ; Li CB Biochem Genet; 2019 Feb; 57(1):147-158. PubMed ID: 30073577 [TBL] [Abstract][Full Text] [Related]
16. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer. Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607 [TBL] [Abstract][Full Text] [Related]
17. The Variant rs145204276 of GAS5 is Associated with the Development and Prognosis of Gastric Cancer. Li QJ; Ma G; Guo HM; Sun SH; Xu Y; Wang BJ J Gastrointestin Liver Dis; 2018 Mar; 27(1):19-24. PubMed ID: 29557411 [TBL] [Abstract][Full Text] [Related]
18. Association of the lncRNA-GAS5 promoter region rs145204276 polymorphism with sevoflurane maintenance anesthesia outcomes on patients undergoing laparoscopic cholecystectomy. Zhang P; Sha Z Saudi Med J; 2023 Feb; 44(2):137-144. PubMed ID: 36773978 [TBL] [Abstract][Full Text] [Related]
19. LncRNA GAS5 rs145204276 Polymorphism Reduces Renal Cell Carcinoma Susceptibility in Southern Chinese Population. Xiang X; Chen L; He J; Ma G; Li Y J Inflamm Res; 2022; 15():1147-1158. PubMed ID: 35210817 [TBL] [Abstract][Full Text] [Related]
20. Impact of LncRNA GAS5 Genetic Variants and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma Patients. Hsieh MH; Wu YL; Tsao TC; Huang YW; Lin JC; Lee CY; Hsieh MJ; Yang SF Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]